dextroamphetamine has been researched along with Space Adaptation Syndrome in 8 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We estimated bioavailability of four different oral formulations used by the NASA RGO physicians for the treatment of motion sickness." | 2.73 | Relative bioavailability of scopolamine dosage forms and interaction with dextroamphetamine. ( Boyd, JL; Du, B; Locke, JP; Putcha, L; Vaksman, Z, 2007) |
| "promethazine and 6 of 8 treated with promethazine suppositories after symptom development had immediate (within 1-2 h) symptom relief and required no additional medication." | 1.29 | Comparison of treatment strategies for Space Motion Sickness. ( Beck, BG; Davis, JR; Jennings, RT, 1993) |
| "Cases of Space Motion Sickness were graded as mild, moderate or severe based on published criteria, and medication effectiveness was judged based on subjective reports of symptom relief." | 1.28 | Comparison of treatment strategies for Space Motion Sickness. ( Beck, BG; Davis, JR; Jennings, RT, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boyd, JL | 1 |
| Du, B | 1 |
| Vaksman, Z | 1 |
| Locke, JP | 1 |
| Putcha, L | 1 |
| Dobie, TG | 1 |
| May, JG | 1 |
| Oman, CM | 1 |
| Oman, C | 1 |
| Davis, JR | 2 |
| Jennings, RT | 2 |
| Beck, BG | 2 |
| Vernikos-Danellis, J | 1 |
| Winget, CM | 1 |
| Leach, CS | 1 |
| Rosenblatt, LS | 1 |
| Lyman, J | 1 |
| Beljan, JR | 1 |
| Graybiel, A | 1 |
1 review available for dextroamphetamine and Space Adaptation Syndrome
| Article | Year |
|---|---|
Cognitive-behavioral management of motion sickness.
Topics: Biofeedback, Psychology; Cinnarizine; Cognitive Behavioral Therapy; Desensitization, Psychologic; De | 1994 |
1 trial available for dextroamphetamine and Space Adaptation Syndrome
| Article | Year |
|---|---|
Relative bioavailability of scopolamine dosage forms and interaction with dextroamphetamine.
Topics: Administration, Oral; Adult; Antiemetics; Biological Availability; Capsules; Cognition; Dextroamphet | 2007 |
6 other studies available for dextroamphetamine and Space Adaptation Syndrome
| Article | Year |
|---|---|
Spacelab experiments on space motion sickness.
Topics: Adaptation, Physiological; Adrenergic Agents; Antiemetics; Dextroamphetamine; Disease Susceptibility | 1987 |
Why do astronauts suffer space sickness?
Topics: Antiemetics; Astronauts; Dextroamphetamine; Head Movements; Humans; Male; Scopolamine; Space Flight; | 1984 |
Comparison of treatment strategies for Space Motion Sickness.
Topics: Aerospace Medicine; Antiemetics; Astronauts; Central Nervous System Stimulants; Dextroamphetamine; H | 1992 |
Comparison of treatment strategies for Space Motion Sickness.
Topics: Aerospace Medicine; Antiemetics; Dextroamphetamine; Female; Humans; Male; Promethazine; Scopolamine; | 1993 |
Space motion sickness medications: interference with biomedical parameters.
Topics: Adult; Antiemetics; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship | 1977 |
The prevention of motion sickness in orbital flight.
Topics: Aerospace Medicine; Antiemetics; Dextroamphetamine; Dimenhydrinate; Ephedrine; Head Movements; Hista | 1976 |